Concentrations of the synthetic polymer polyriboinosinic polyribocytidylic acid that produced no detectable toxicity in normal L cells produced marked cytotoxicity in L cells treated with interferon. This increase in the susceptibility of cells to the toxicity of the polymer was also observed in human cells and secondary mouse embryo cells treated with homologous interferons before exposure to the polynucleotides. The degree of enhancement of toxicity was dependent on the concentration of interferon to which the cells were exposed. The ratio of antiviral activity induced by interferon to enhancement of toxicity by interferon remained constant through about 1000-fold purification. Various interferon preparations induced by viruses or by polyriboinosinic polyribocytidylic acid in vivo or in vitro, and international reference standard interferons all exhibited enhancement of toxicity. Both enhancement of toxicity and antiviral activity were destroyed by trypsin and by incubation at 56°for 1 hr, did not act on heterologous cells, were not sedimented by ultracentrifugation, and were not inactivated by ribonuclease, deoxyribonuclease, irradiation with ultraviolet light, or exposure to a pH of 2.
The toxicity of polynucleotides that induce interferon seems to increase in parallel with their ability to induce production of interferon (ref. 1 , and E. De Clereq, W. E. Stewart II, and P. De Somer, in preparation), suggesting that the toxic and interferon-inducing properties of these polynucleotides are inseparable. However, the recent finding that cells treated with interferon can be induced to produce interferon by con- centrations of poly(I. C) that are too low to induce interferon production in untreated cells (2) presented us with alternative interpretations: either that cells treated with interferon can be stimulated by less toxic concentrations of inducer than those needed to stimulate untreated cells, and therefore the toxic and interferon-inducing properties of poly(I C) are separable, or that cells treated with interferon are more susceptible than untreated cells to the toxicity of poly(I-C).
Our data show that cells treated with interferon are more susceptible to the toxicity of poly(I* C) than untreated cells.
MATERIALS AND METHODS
Cells and Viruses. Monolayer cultures of L-929 cells, secondary mouse-embryo cells, and human embryonic skin fibroblasts were grown in Eagle's minimal essential medium (ME medium) containing 3% calf serum, penicillin (100 units/ml), and streptomycin (100 ug/ml). Cultures for use in experiments were grown in 60-mm plastic plates (Falcon Plastics) and contained about 106 cells at the beginning of the experiments. Vesicular stomatitis virus (VSV), Newcastle disease virus (NDV), and MIM virus were prepared as described (2) .
Treatment of Cells with Poly(I -C). Poly(I C) was prepared by annealing the individual homopolymers, both purchased from P-L Biochemicals, Inc., Milwaukee, Wis., or from Miles Laboratories, Elkhart, Ind., in equal amounts (1 mg/ml) in 0.15 M NaCl at 450 for 1 hr. Poly(ID C) was stored frozen in aliquots of 1 ml at -20°. Cultures were exposed for 1 hr at 370 to 1 ml of the indicated concentrations of poly(I-C) that had been warmed to 37°immediately before use.
Interferons. Human interferons were prepared by inoculation of cultures of human embryonic skin fibroblasts with either 50 jig of poly(I* C) or MM virus at a multiplicity of infection of 
RESULTS
Monolayer cultures of untreated L cells were exposed to various concentrations of poly(I C), washed, and incubated overnight with serum-free ME medium. None of these concentrations of poly(I C) induced detectable interferon production or caused discernible visual cellular toxicity (Table 1) . However, when L-cells that were treated with interferon, were exposed to poly(I* C), all of the concentrations of poly-(I C) used induced interferon production and caused visible toxicity that increased with increasing concentrations of interferon that was used for prior treatment of cells. Cytotox-1851 Abbreviations: ME medium, Eagle's minimal essential medium; VSV, vesicular stomatitis virus; NDV, Newcastle disease virus; CPE, cytopathic effect; PDDbo, the dilution of interferon that depresses the number of plaques of a virus by 50%. icity was also measured by determination of the inhibition of uptake of neutral red and by determination of cell viability by detection of permeability to trypan blue (3). Cells treated with interferon showed significant and consistant enhancement of toxicity by all three measurements. Identical results were obtained with poly(I C) obtained from different suppliers.
Mouse interferon also enhanced the susceptibility of secondary mouse embryo fibroblast cultures to the toxicity of poly(I. C), and human interferon enhanced the susceptibility of human embryonic skin fibroblasts to the toxicity of poly-(I C) ( Table 2 ). In cultures of treated mouse embryo fibroblasts, cytopathic effect (CPE) was virtually indistinguishable 16 hr after exposure to poly(I C) but became very pronounced by 40 hr. Human fibroblasts required about five times more poly(I* C) to exhibit cytotoxicity than b-cells.
We have determined that the enhancement of toxicity is attributable to interferon by correlation of enhancement of toxicity and antiviral activity in interferon preparations ( Table 3 ). Treatments that destroyed antiviral activity also units/mg of protein, and have found this ratio to remain constant with increasing purification.
DISCUSSION
Several reports have provided evidence that cells treated with interferon are more susceptible than untreated cells to toxic substances. An exaggerated disintegration has been reported to occur in L-cells treated with interferon after infection with poxvirus (4), and it has been proposed that a cellular alteration induced by interferon together with a virus-specific effect could account for this early degeneration of cells treated with interferon (5). Interferon inducers have been found to enhance the lethality due to endotoxins in mice, and it was suggested that this enhanced lethality is mediated by interferon (6, 7) . Our data show that, indeed, interferon does alter cells in such a way that they become more susceptible than cells unexposed to interferon to the toxicity of poly(I C) Further studies should reveal whether this enhancement of toxicity by interferon makes cells more susceptible to classes of toxic materials other than substances that induce interferon.
The inability of even relatively high concentrations of poly(I C) to induce interferon production in I-cells in the absence of DEAE-dextran is well documented (8) (9) (10) (11) (12) . Since it has been suggested that DEAE-dextran potentiates interferon induction by rendering the inducer less susceptible to endonucleases (13, 14) , the finding that poly(I* C) is able to induce interferon production in Lcells treated with interferon in the absence of DEAE-dextran suggests that poly-(I. C) may be less susceptible to enzymatic degradation in cells treated with interferon. The increased ability of polynucleotides to resist enzymatic degradation might also account for their increased toxicity to cells treated with interferon, since increased resistance of polynucleotides to endonucleases appears to correlate with increased interferoninducing ability (15) (16) (17) . This interpretation is particularly intriguing in view of the recent reports that functioning of virion-associated polymerases is inhibited in cells treated with interferon (18, 19) . It is tempting to speculate that interferon-induced antiviral activity and interferon-induced enhancement of toxicity may function through a common mechanism: inhibition of enzymatic activity. Inhibition of polymerase activity would inhibit virus replication and inhibition of endonuclease activity would increase both the toxicity and the interferon-inducing ability of poly(I. C). The possibility also exists that cells treated with interferon are able to bind more polymer than untreated cells.
Another alteration of cells by interferon that has received considerable attention is its ability to inhibit the growth of cells (20) (21) (22) (23) (24) (25) (26) (27) . Recently, it has been speculated that "interferon renders cells more sensitive to the various mechanisms that limit cell division as cell density increases" (25) . In view of the present findings that interferon renders cells more sensitive to the toxicity of poly(I* C), it seems reasonable to propose that growth inhibition observed in cultures treated with interferon is a consequence of the enhancement of toxicity by interferon that makes the cells more sensitive to toxic products of their metabolism.
In view of the potential importance of poly(I. C) in treatment of human beings (28), we feel that the present findings should be taken into consideration in safety evaluations of this in vitro, are based on detection of the toxicity of poly(I* C) in normal cells (29) (30) (31) . However, the presence of infectioninduced interferon in potential candidates for therapy with poly(I C) (i.e., virus-infected patients), could make these individuals more susceptible than uninfected individuals to the toxic effects of poly(I C).
